You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Whole genome sequencing in pharmacogenomics
|
|---|---|
| Published in |
Frontiers in Pharmacology, March 2015
|
| DOI | 10.3389/fphar.2015.00061 |
| Pubmed ID | |
| Authors |
Theodora Katsila, George P Patrinos |
| Abstract |
Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug-gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacogenomic testing are still in their infancy, whereas the emerging high throughput genotyping technologies produce a tsunami of new findings. Herein, the potential of whole genome sequencing on pharmacogenomics research and clinical application are highlighted. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 20% |
| India | 1 | 20% |
| Israel | 1 | 20% |
| Switzerland | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 3 | 60% |
| Members of the public | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 2 | 2% |
| Unknown | 90 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 22% |
| Student > Master | 16 | 17% |
| Student > Ph. D. Student | 12 | 13% |
| Student > Bachelor | 10 | 11% |
| Other | 3 | 3% |
| Other | 11 | 12% |
| Unknown | 20 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 28 | 30% |
| Medicine and Dentistry | 12 | 13% |
| Agricultural and Biological Sciences | 11 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Computer Science | 3 | 3% |
| Other | 8 | 9% |
| Unknown | 25 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2015.
All research outputs
#13,938,371
of 22,796,179 outputs
Outputs from Frontiers in Pharmacology
#4,284
of 16,014 outputs
Outputs of similar age
#134,328
of 263,459 outputs
Outputs of similar age from Frontiers in Pharmacology
#27
of 82 outputs
Altmetric has tracked 22,796,179 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,014 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,459 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.